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Objective:Overthelast50years,therehasbeenasurgeofinterestbyboththepublicand
medical practitioners in therapies and disciplines that are not considered part of main-
stream medical care. The title given to these is complementary and alternative medicine.
Of all these branches, our interest is the increasing use of herbal medicines, traditional
medicines (such as Chinese or Indian), homeopathy and “dietary supplements,” and the
inﬂuence they may have on our practice. Our objective was to examine the prevalence
andreasonsforuseofcomplementaryandalternativemedicines,thecurrentregulations,
and proposed policy changes affecting the licensing of these products. In addition, we
highlight some of the problems that have been experienced with herbal and traditional
medicines. Methods: A prospective analysis of herbal and over the counter medicines
used by elective plastic surgery patients. Results: Of 100 elective plastic surgery pa-
tients undergoing procedures at St Andrew’s Centre for Burns and Plastic Surgery, 44%
of patients were taking a dietary supplement, herbal, or homeopathic remedy. In none
of the patients was this documented in the notes by either the surgeon or anesthetist.
Conclusions: We recommend that clear documentation of the use of nonprescribed
medicines becomes part of standard practice and, furthermore, that patients stop all such
medications 2 weeks prior to surgery until the efﬁcacy, interactions, and safety proﬁles
are clearly established.
BACKGROUND
The ﬁrst synthetic chemical drug was aspirin, manufactured by Bayer in Germany, and put
on the market in 1899. Prior to this, western medicine has been similar to that practiced
in all other parts of the world (such as Chinese or Ayurvedic) in that it was mainly based
on the use of plants and herbs, animal preparations with possibly the addition of metal
compounds.1
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Since 1899, the number and use of synthetic drugs has increased hugely making it
the mainstay treatment for the majority of medical practitioners. Concurrently with great
pharmaceutical advances have been improvements in diagnosis and surgical innovations of
which plastic surgery has often been at the forefront.
For a variety of reasons, over the last 50 years, however, there has been a surge of
interest by both the public and medical practitioners in therapies and disciplines that are
not considered part of mainstream medical care. The title given to these is complementary
and alternative medicine (CAM)
This title encompasses disciplines as wide ranging as aromatherapy to acupuncture
and homeopathy to osteopathy. It is only recently that some UK medical schools have made
the study of CAM, a part of the curriculum.
Of all these branches of CAM, our interest is the increasing use of herbal medicines,
traditional medicines (such as Chinese or Indian), homeopathy, and “dietary supplements”
and the inﬂuence they may have on our practice.
PREVALENCE OF CAM USE
Figures vary in studies over the world but all tend to show an increase in CAM. A telephone
survey conducted by British Broadcasting Corporation in 1999 showed 20% of people had
used some form of CAM in the preceding year, 34% of which had taken herbal remedy.2
A larger postal survey of CAM use in England found 8.6% of respondents had bought
an over the counter homeopathic remedy and 19.8% had bought an over the counter herbal
remedy.3
Around the time of these studies, sales of complementary medicines (deﬁned here as
herbal, homeopathic, and aromatherapy essential oils) totaled £93 million in 19981 and had
increased to £130 million in 2002. They now total an estimated £213 million per annum
on the basis of work by market researchers Mintel.4 Sales of herbal remedies alone were
£43.7 million in 1997, £65 million in 2000, and forecasted to be £117 million in 2007.4
The UK picture echoes a similar scene in the United States where herbal medicine use
has increased from 2.5% in 1990 to 12.1% in 1997. Expenditure on alternative therapies
was estimated to be $21.0 billion in 19975 that rose to $27.0 billion by 2005, with one-third
of the American public using CAMs.47
THE REASONS FOR USING CAMs
The hypotheses for why patients may choose CAMs are multiple. For some patients, it is
a way of empowerment and allowing greater control over their health care decisions.6 For
others, it may be a distrust or dissatisfaction with conventional medicine, physicians, or
hospitals7; although, it must be noted that many patients use CAMs in conjunction with
conventional treatments8 and often for health maintenance rather than to treat a speciﬁc
ailment. For many, however, it is due to a successful resolution or reduction of symptoms or
as part of the patient’s life style or philosophy of life.9 For others, it may be through media
exposure of celebrities using CAMs.13 When given a range of statements questioning why
they used herbal or homeopathic remedies, 43% of respondents cited recommendations by
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family or friends while only 18% claimed it was because of concern of the side effects of
standard medications.4
A US postal survey looked at why people access CAM and predictors for CAM use.
In addition to those factors noted earlier, chronic health problems (ie, anxiety, pain, back
problems) were also found to be associated with CAM use.9,11
SigniﬁcantpredictorsforCAMusehavealsofoundtobeofhigh-educationalstatus,7,11
overall health status,9,10 female sex,6,10 and higher than average social class.6 There is also
a geographical component to CAM use in the United Kingdom, with a higher proportion
of residents in London using herbal or homeopathic remedies compared with other parts of
the United Kingdom.4
REGULATION AND POLICY
A key concern in recent years is the level of regulation that herbal and traditional remedies
have.
Article 1 of European Council Directive 2004/27/EC as amended deﬁnes a “medicinal
product” as
(a) Any substance or combination of substances presented as having properties for treating or
preventing disease in human beings;
(b) Any substance or combination of substances, which may be used in or administered to human
beings either with a view to restoring, correcting or modifying physiological functions, by exerting a
pharmacological, immunological or metabolic action, or to making a medical diagnosis.12
This in effect means that any product supplied with therapeutic intent (eg, by having
a claim on the label) is a medical product. Therefore, all products that make claims to treat
diseases are considered medicines and subject to regulation by European Union Directives
and the Medicine Act. All products that make a medicinal claim require a product license
(also referred to as marketing authorization by the Medical Control Agency) to ensure a
certain standard of quality and safety.
Some herbs are currently exempted from licensing if they meet certain conditions
(Section12MedicinesAct,1968),whichallowssalesofherbalremedies(withoutmedicinal
claims) if the manufacturing process is simple (ie, consists of drying or crushing) or if
supplied to individual patients following a face-to-face consultation.
Because of differing regulations and uncertainty in the classiﬁcations of herbal reme-
dies in the EU member states, a new scheme was introduced in October 2005—the Tra-
ditional Herbal Medicines Registration Scheme. This is designed to protect public health
by requiring speciﬁc standards of safety and quality for traditional herbal medicines. This
scheme is required by the European Directive on Traditional Herbal Medicinal Products
(2004/24/EC).
This scheme has 2 methods of registration. First, medical use registration (which is
similar to the previously used product licence), which means they have achieved marketing
authorization,thiswillincludeallthoseherbsthathavebeenauditedtopharmaceuticalstan-
dards and can make claims regarding use and efﬁcacy. Second, traditional use registration
for those herbs that do not fulﬁl the criteria of the previous category but are manufactured
on licensed premises and can supply evidence of “well-established medical use,” which
is deﬁned as medical use in the European Union for 30 years (products from outside the
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European Union must prove at least 15 years within Europe and 15 years outside Europe).
By April 2011, all manufactured herbal medicines sold over the counter will be required to
have either a traditional herbal registration or a product license.48
Because of the difﬁculty in getting new herbal remedies market authorization many
herbal products, especially from China and India are not licensed as medicines and are,
therefore, supplied to the public without speciﬁc regulations. This means that standards of
preparation and content can vary greatly between products bought over the counter.
POTENTIAL PROBLEMS
There are several areas of concern with the increased use of ingested complementary or
alternative medicines. The ﬁrst area, mentioned earlier, which is currently being addressed,
is the regulation ensuring conditions of use and standards of efﬁcacy and safety.
Second is the possibility of side effects from use of nonprescribed medication. A
common misperception is that herbal remedies are somehow more natural and, therefore,
safer. However, side effects of herbal remedies are more frequently being reported whether
through increased usage and awareness or whether the fact that easier routes for reporting
side effects are now available is unclear.
A number of well-recognized herbal remedies have been found to be associated with
serious side effects or toxicity.
A recently reported example of a commonly use herbal remedy with serious side
effects is Kava. Kava-kava is a perennial shrub native to some islands of the South Paciﬁc
from which a psychoactive drink can be made. In Paciﬁc Island societies, it is sometimes
used for ceremonial as well as medicinal purposes.14 In Europe, its extracts have been
used as an anxiolytic. In January 2003, the government prohibited Kava-kava in unlicensed
herbal medicines following reports worldwide of idiosyncratic liver damage associated
with the consumption of Kava-kava. This was on the basis of advice from the committee on
the safety of medicines that Kava-kava posed a rare but serious risk to public health. There
have been a number case reports in the literature.15,16
Other herbal remedies have been associated with hepatotoxic events15,m a n yo ft h e m
herbs used in Chinese traditional medicines.
A third possible problem identiﬁed is the interaction of herbal remedies with concur-
rently prescribed medicine. An example is St John’s Wort (Hypericum perforatum), which
has been used to treat depression. Although a previously popular remedy available over
the counter, it was found that Hypericum is a potent inducer of several cytochrome P450
enzymes15,17-19and has been associated with a number of cases of drug interactions.20-22
A further point of concern is the possible contamination of herbal remedies. The
contamination may be related to the environment in which the herbs or plants are grown or
may occur during the processing of the substances in question. There have been concerns
that without careful monitoring high-organochlorine pesticides levels may contaminate
herbal medicines, especially those in which the stems, roots, or tubers are used.23,24
Contaminationbyheavymetals,25 whichisparticularlyprevalentinChinesetraditional
medicines26-28hasalsobeenfound.Therearecasesofpoisoningwithlead29-31,33,arsenic29,
thallium32, cadmium,33,34 and mercury.33 A Taiwanese study looked at a randomly selected
group of 2803 patients and screened them all for elevated blood lead levels. A history of
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using traditional Chinese medicines was shown to a signiﬁcant risk factor for raised blood
leadlevels,35 whichmaysuggesttheproblemmaybemorewidespreadthanthecasereports
indicate.
A ﬁnal potential problem of CAMs is that of adulteration. There have been a number
of case reports and studies into adulteration of herbal remedies, with the adulterants often
posing a signiﬁcant risk.14,36 A study in Taiwan found that 24% of all samples of traditional
Chinese medicines contained adulterants, half of which contained 2 or more adulterants.37
In addition to this, adulteration has also been found in homeopathic treatments.40
PATIENT SURVEY
To examine our own patient group a survey of 100-elective plastic surgery patients was
conducted. All patients were preclerked prior to the day of operation. Their notes were
checked to see whether any herbal/Chinese/homeopathic or over the counter medicines
had been documented by either the anesthetist or the doctor that had performed the patient
clerking.Thepatientswerethenaskedwhethertheywerecurrentlytakinganynonprescribed
remedies. A list of 13 commonly used over the counter remedies were used to guide the
patients. Any treatments not listed were also noted. The age and sex of the patients was
recorded and vitamin and mineral supplements were also noted
Results were tabulated and differences in the use of herbal or homeopathic treatments
compared to the age and sex of the patient were tested using χ2 analysis. A P value of less
than .05 was considered statistically signiﬁcant.
RESULTS
Of 100 elective plastic surgery patients undergoing procedures at St Andrew’s Centre for
Burns and Plastic Surgery, Chelmsford, 44% of patients were taking a dietary supplement,
herbal or homeopathic remedy of which 17% were taking a herbal or homeopathic remedy
see Table 1.
Table 1. The percentage of patients taking un-
prescribed over the counter remedies
Type of supplement taken Percentage of patients
Dietary supplement 37
Herbal supplement 15
Homeopathic remedy 2
Male-female ratio was 22:78. The average age of female patients was 56.96 years,
range: 16 to 95 years; average age of male patients was 54.54 years, range: 18 to 104 years
(see Table 2). Some patients took more than 1 type of over-the-counter medicine with one
patient taking 8 supplementary nonprescribed tablets and a topical application of a further
remedy.
A wide variety of herbal medicines are being taken by the patients, as evidenced by
16 different types of herbal remedies being ingested by the 15 patients (Table 3). Twelve
248COLLINS ET AL
Table 2. Age ranges of patients and over the counter remedies taken
Percent taking Percent taking Percent taking
Age range, y No. of patients herbal remedies vitamin supplements dietary supplements
15-19 5 0 0 0
20-24 5 40 0 0
25-34 8 25 25 0
35-44 10 20 50 20
45-54 12 17 33 25
55-64 23 26 22 35
65+ 37 3 16 24
different types of vitamin or dietary supplement were used, the most common supplements
being cod liver oil tablets and multivitamins.
Fourteenofthe15patientstakingherbalremedieswerefemale(P <.05)withonemale
and one female patient taking a homeopathic remedy. Interestingly of the 2 patients taking
homeopathic, neither of these patients knew what the name or content of the treatment they
were ingesting.
Of all patients investigated, there was no record in the surgical preoperative clerking
or anesthetic records of CAM use.
DISCUSSION
The use of complementary and alternative medicines is growing in the United Kingdom.
The use of herbal, homeopathic, and traditional remedies such as Chinese and Indian
remedies form part of this market and may have a profound impact on patient outcomes
perioperatively.
Our survey shows that a substantial number of patients are taking food supplements,
homeopathic, or herbal remedies (44%)—a ﬁgure that endorses the growing use of CAMs
described in the literature. Evidence shows that this market is growing in the United
Kingdom and is following the trend seen in the United States over the last 2 decades. In
addition, this market is also projected to continue growing.
Of the patients using CAMs a large proportion are taking herbal remedies, the group
that potentially is in the most danger are those taking them perioperatively. Again our
ﬁndings echo those of other larger studies both in the United Kingdom and in the United
States although a comprehensive study in the United Kingdom in 2002 found a smaller
(4.8%) proportion taking herbal remedies.38 However, this level of herbal use is in line with
other studies.3 The typical patient taking a herbal remedy is female, middle aged, and often
from a higher-income household, a demographic that forms a large proportion of elective
plastic surgery patients especially in the private sector.
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Table 3. Individual herbal remedies and dietary/food
supplements ingested
Remedy n %
A∗
Arnica 1 4.8
Blueberry tablet with marigold 1 4.8
Aloe vera tablets 1 4.8
Black cohosh 1 4.8
Echinacea 2 9.6
Evening primrose oil 4 19.0
Garlic 2 9.6
Green tea tablets 1 4.8
Horse chestnut 1 4.8
Milk thistle 1 4.8
Periwinkle 1 4.8
Sage leaf capsules 1 4.8
Soya isoﬂavan 1 4.8
Star ﬂower oil 1 4.8
Symphytum 1 4.8
Whole birch 1 4.8
B†
Multivitamins 15 25.0
Vitamin B 2 3.4
Vitamin C 7 12.0
Vitamin E 2 3.4
Calcium 1 1.7
Magnesium 1 1.7
Iron 1 1.7
Zinc 2 3.4
Cod liver oil 16 27.0
Glucosamine 7 12.0
Omega III 4 6.8
Lutein tablets 1 1.7
∗Herbal remedies taken by 15 patients (n = 21).
†Vitamins and dietary supplements taken by 37 patients (n = 59).
Although the regulation of herbal and traditional medicines is changing, there are
concernsthattheincreaseddifﬁcultyingettinganewdruglicensedmeansmorecompounds
will not be marketed as medicines and, therefore, be supplied without speciﬁc regulations.
Therefore, surgeons and anesthetists should be particularly aware of potential interactions
and side effects of the most commonly used CAMs. Two other useful studies have looked at
the most frequently used CAMs in plastic surgery patients as well as potential interactions
and complications.41,42 Even after the regulations come into effect awareness should still
be maintained as the source of the treatment cannot always be veriﬁed (especially if bought
over the internet or brought from a country with less stringent regulation). A study of 443
Web sites found that a signiﬁcant proportion made unveriﬁable or illegal claims regarding
the herbal remedies or nutritional supplements advertised.43
Our study shows that both surgeons and anesthetists poorly record the documentation
of the use of CAMs by patients, as we did not ﬁnd their use documented in either the
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surgical preoperative patient clerking or in the anesthetic records of a single patient that
wasinvestigated.Wecouldnot,however,establishinallcaseswhetherthepatientshadbeen
asked and either CAM use was not recorded or not thought to be sufﬁciently important to
document. A survey of anesthetic practice in the United Kingdom highlighted this problem
by showing that 90% of the anesthetists questioned stated that they seldom or never asked
patientsaboutherbalmedicineusage.44 Afurtherproblemisthattheinformationisunlikely
to be volunteered by the patient. Around 70% of patients do not disclose the fact that they
are using a CAM to theirdoctor.45 This studylisteda varietyof reasons including“It wasn’t
important for the doctor to know,” “The doctor never asked,” “It was none of the doctor’s
business” with some respondents thinking their doctor would disapprove of or discourage
CAM use.
We suggest that the questioning of all patients and clear documentation regarding the
use or not of CAMs and over the counter drugs becomes part of standard practice. A useful
mnemonic has been made speciﬁcally for this purpose.39
Suggestions have been made for the time period for stopping certain herbal remedies
prior to surgery,46 however, until the regulations are enforced we follow the American Soci-
ety of Anaesthesiologists recommendations that patients stop all such medications 2 weeks
prior to surgery until the efﬁcacy, interactions and safety proﬁles are clearly established.
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